FDA Approves Expanded Use Of Lilly's Jaypirca For CLL/SLL3 reports from 3 outlets in 1 language · first reported 2026-10-02 19:51 UTC · updated 2026-10-03 15:22 UTC · JSONHealthLillyUnited States Food and Drug Administrationpirtobrutinibchronic lymphocytic leukemiaSLLReportsFDA Approves Expanded Use Of Lilly's Jaypirca For CLL/SLLPublished by finanzen.ch, rttnews.com · 2026-10-03 15:22 UTCFDA Approves Jaypirca as First-Line Treatment for CLL and SLLcuretoday.com · en · 2026-10-02 19:51 UTC